Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 12, 2017Analyses Evaluated the Impact of Ethnicity, Gender and Income on Cardiovascular Outcomes
Analyses evaluated the impact of ethnicity, gender and income on cardiovascular outcomes
-
May 11, 2017Late-Breaker Data Presented at Heart Rhythm 2017
Late-breaker data presented at Heart Rhythm 2017
-
May 9, 2017New Devices Combine Longest-Lasting Battery Technology, Therapy Optimization and HeartLogic™ Heart Failure Diagnostics
New devices combine longest-lasting battery technology, therapy optimization and HeartLogic™ heart failure diagnostics
-
Apr 27, 2017
"We are pleased with our performance in the first quarter,” said CEO Mike Mahoney
-
Apr 18, 2017MADIT S-ICD Trial to Study EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System; Trial Recruitment Part of Pilot Initiative to Increase Percentage of Females Enrolled in Clinical Studies
MADIT S-ICD trial to study EMBLEM™ MRI S-ICD System; part of pilot initiative to increase percentage of females enrolled in clinical studies
-
Mar 30, 2017Acquisition Will Expand Treatments for Patients with Valvular Heart Disease and Strengthen Company's Position in Structural Heart Globally
Acquisition will expand treatments for patients with valvular heart disease and strengthen company's position in structural heart globally
-
Mar 16, 2017Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; has potential for significant cost savings
Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; potential for significant cost savings
-
Mar 9, 2017Edwards Found to Infringe on Boston Scientific Patents in Germany and U.K.
Edwards found to infringe on Boston Scientific patents in Germany and U.K.
-
Feb 2, 2017
"Boston Scientific delivered excellent financial results in 2016,” said CEO Mike Mahoney
-
Dec 13, 2016
Acquisition will bring manufacturing assets and biologic tissue capabilities for use in Boston Scientific heart valve technologies.